23andMe is a consumer facing genetics and research company conducting independent research in genomics, diseases and drug development. Known for offering an FDA-authorized genotyping service, 23andMe allows users to learn about their ancestry and genetic health risks. The aim of this project is to create a procedure to evaluate the price performance of 23andMe’s GWAS algorithm on Amazon Web Service’s ARM processors in comparison to their current workflow which utilizes Intel’s x86 processors.